Search research articles
Contact Us
Filters
Showing results (871-880 of 964) with videos related to
Page
of 97
Sort By:
The Journal of Clinical Investigation
|
September 1, 1996
Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz
P J O'Dwyer, C E Szarka, K S Yao, et al.
Schizophrenia Research
|
July 23, 2016
Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing
Amanda McCleery, Junghee Lee, Alan P Fiske, et al.
Schizophrenia Research
|
February 26, 2019
The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial
Destiny L Peterson, Christopher A Webb, Jared W Keeley, et al.
Schizophrenia Bulletin
|
February 25, 2011
Social cognition in schizophrenia, Part 1: performance across phase of illness
Michael F Green, Carrie E Bearden, Tyrone D Cannon, et al.
Journal of Gastrointestinal Oncology
|
November 16, 2023
Identification of an optimal mutant allele frequency to detect activating <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas
Bennett A Caughey, Kumiko Umemoto, Michelle F Green, et al.
Molecular Diagnosis & Therapy
|
June 7, 2025
Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage
Michelle F Green, Zachary D Wallen, Heidi C Ko, et al.
Biological Psychiatry
|
May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders
Cameron S Carter, Deanna M Barch, Edward Bullmore, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 12, 2021
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Mario Maj, Jim van Os, Marc De Hert, et al.
Journal of Abnormal Psychology
|
October 15, 2014
Social cognition and functional outcome in schizophrenia: The moderating role of cardiac vagal tone
Holly K Hamilton, Jane C Sun, Michael F Green, et al.
Biological Psychiatry
|
September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
Michael F Green, Keith H Nuechterlein, James M Gold, et al.
Page
of 97
Search research articles
Search
Showing results (871-880 of 964) with videos related to
Sort By:
Page
of 97
The Journal of Clinical Investigation
|
September 1, 1996
Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz
P J O'Dwyer, C E Szarka, K S Yao, et al.
Schizophrenia Research
|
July 23, 2016
Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing
Amanda McCleery, Junghee Lee, Alan P Fiske, et al.
Schizophrenia Research
|
February 26, 2019
The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial
Destiny L Peterson, Christopher A Webb, Jared W Keeley, et al.
Schizophrenia Bulletin
|
February 25, 2011
Social cognition in schizophrenia, Part 1: performance across phase of illness
Michael F Green, Carrie E Bearden, Tyrone D Cannon, et al.
Journal of Gastrointestinal Oncology
|
November 16, 2023
Identification of an optimal mutant allele frequency to detect activating <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas
Bennett A Caughey, Kumiko Umemoto, Michelle F Green, et al.
Molecular Diagnosis & Therapy
|
June 7, 2025
Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage
Michelle F Green, Zachary D Wallen, Heidi C Ko, et al.
Biological Psychiatry
|
May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders
Cameron S Carter, Deanna M Barch, Edward Bullmore, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 12, 2021
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Mario Maj, Jim van Os, Marc De Hert, et al.
Journal of Abnormal Psychology
|
October 15, 2014
Social cognition and functional outcome in schizophrenia: The moderating role of cardiac vagal tone
Holly K Hamilton, Jane C Sun, Michael F Green, et al.
Biological Psychiatry
|
September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
Michael F Green, Keith H Nuechterlein, James M Gold, et al.
Page
of 97